165 related articles for article (PubMed ID: 30772928)
1. Neuroendocrine Neoplasms Associated with Germline Pathogenic Variants in the Homologous Recombination Pathway.
Szybowska M; Mete O; Weber E; Silver J; Kim RH
Endocr Pathol; 2019 Sep; 30(3):237-245. PubMed ID: 30772928
[TBL] [Abstract][Full Text] [Related]
2. Homologous Recombination Deficiencies and Hereditary Tumors.
Yamamoto H; Hirasawa A
Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008774
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Homologous Recombination Deficiency Among Patients With Germline RAD51C/D Breast or Ovarian Cancer.
Torres-Esquius S; Llop-Guevara A; Gutiérrez-Enríquez S; Romey M; Teulé À; Llort G; Herrero A; Sánchez-Henarejos P; Vallmajó A; González-Santiago S; Chirivella I; Cano JM; Graña B; Simonetti S; Díaz de Corcuera I; Ramon Y Cajal T; Sanz J; Serrano S; Otero A; Churruca C; Sánchez-Heras AB; Servitja S; Guillén-Ponce C; Brunet J; Denkert C; Serra V; Balmaña J
JAMA Netw Open; 2024 Apr; 7(4):e247811. PubMed ID: 38648056
[TBL] [Abstract][Full Text] [Related]
4. Genomic Methods Identify Homologous Recombination Deficiency in Pancreas Adenocarcinoma and Optimize Treatment Selection.
Park W; Chen J; Chou JF; Varghese AM; Yu KH; Wong W; Capanu M; Balachandran V; McIntyre CA; El Dika I; Khalil DN; Harding JJ; Ghalehsari N; McKinnell Z; Chalasani SB; Makarov V; Selenica P; Pei X; Lecomte N; Kelsen DP; Abou-Alfa GK; Robson ME; Zhang L; Berger MF; Schultz N; Chan TA; Powell SN; Reis-Filho JS; Iacobuzio-Donahue CA; Riaz N; O'Reilly EM
Clin Cancer Res; 2020 Jul; 26(13):3239-3247. PubMed ID: 32444418
[TBL] [Abstract][Full Text] [Related]
5. Neuroendocrine Tumor of the Pancreas as a Manifestation of Cowden Syndrome: A Case Report.
Neychev V; Sadowski SM; Zhu J; Allgaeuer M; Kilian K; Meltzer P; Kebebew E
J Clin Endocrinol Metab; 2016 Feb; 101(2):353-8. PubMed ID: 26678657
[TBL] [Abstract][Full Text] [Related]
6. Pathologic findings in breast, fallopian tube, and ovary specimens in non-BRCA hereditary breast and/or ovarian cancer syndromes: a study of 18 patients with deleterious germline mutations in RAD51C, BARD1, BRIP1, PALB2, MUTYH, or CHEK2.
Schoolmeester JK; Moyer AM; Goodenberger ML; Keeney GL; Carter JM; Bakkum-Gamez JN
Hum Pathol; 2017 Dec; 70():14-26. PubMed ID: 28709830
[TBL] [Abstract][Full Text] [Related]
7. Germline pathogenic variants in patients with early-onset neuroendocrine neoplasms.
Riechelmann RP; Donadio MDS; Jesus VHF; de Carvalho NA; Santiago KM; Barros MJ; Lopes L; Oliveira Dos Santos G; Nirvana Formiga M; Carraro DM; Torrezan GT
Endocr Relat Cancer; 2023 Jun; 30(6):. PubMed ID: 36947458
[TBL] [Abstract][Full Text] [Related]
8. Two Germline Pathogenic Variants in Cancer Susceptibility Genes and Their Null Implication in Breast Cancer Pathogenesis: The Importance of Tumoral Homologous Recombination Deficiency Testing.
Rezqallah A; Torres-Esquius S; Llop-Guevara A; Cruellas M; Martinez MT; Romey M; Denkert C; Serra V; Chirivella I; Balmaña J
JCO Precis Oncol; 2024 Mar; 8():e2300446. PubMed ID: 38513169
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic Neuroendocrine Neoplasm Associated with a Familial MAX Deletion.
Petignot S; Daly AF; Castermans E; Korpershoek E; Scagnol I; Beckers P; Dideberg V; Rohmer V; Bours V; Beckers A
Horm Metab Res; 2020 Nov; 52(11):784-787. PubMed ID: 32521546
[TBL] [Abstract][Full Text] [Related]
10. RAD51C germline mutations found in Spanish site-specific breast cancer and breast-ovarian cancer families.
Blanco A; Gutiérrez-Enríquez S; Santamariña M; Montalban G; Bonache S; Balmaña J; Carracedo A; Diez O; Vega A
Breast Cancer Res Treat; 2014 Aug; 147(1):133-43. PubMed ID: 25086635
[TBL] [Abstract][Full Text] [Related]
11. Hereditary cancer variants and homologous recombination deficiency in biliary tract cancer.
Okawa Y; Iwasaki Y; Johnson TA; Ebata N; Inai C; Endo M; Maejima K; Sasagawa S; Fujita M; Matsuda K; Murakami Y; Nakamura T; Hirano S; Momozawa Y; Nakagawa H
J Hepatol; 2023 Feb; 78(2):333-342. PubMed ID: 36243179
[TBL] [Abstract][Full Text] [Related]
12. Discovery of mutations in homologous recombination genes in African-American women with breast cancer.
Ding YC; Adamson AW; Steele L; Bailis AM; John EM; Tomlinson G; Neuhausen SL
Fam Cancer; 2018 Apr; 17(2):187-195. PubMed ID: 28864920
[TBL] [Abstract][Full Text] [Related]
13. Successful mTOR inhibitor therapy for a metastastic neuroendocrine tumour in a patient with a germline TSC2 mutation.
Schrader J; Henes FO; Perez D; Burdak-Rothkamm S; Stein A; Izbicki JR; Lohse AW
Ann Oncol; 2017 Apr; 28(4):904-905. PubMed ID: 28327903
[No Abstract] [Full Text] [Related]
14. Double germline mutations in APC and BRCA2 in an individual with a pancreatic tumor.
Goehringer C; Sutter C; Kloor M; Gebert J; Slater EP; Keller M; Treiber I; Ganschow P; Kadmon M; Moog U
Fam Cancer; 2017 Apr; 16(2):303-309. PubMed ID: 27838800
[TBL] [Abstract][Full Text] [Related]
15. The landscape of molecular alterations in pancreatic and small intestinal neuroendocrine tumours.
Scarpa A
Ann Endocrinol (Paris); 2019 Jun; 80(3):153-158. PubMed ID: 31072588
[TBL] [Abstract][Full Text] [Related]
16. Heterozygous PALB2 c.1592delT mutation channels DNA double-strand break repair into error-prone pathways in breast cancer patients.
Obermeier K; Sachsenweger J; Friedl TW; Pospiech H; Winqvist R; Wiesmüller L
Oncogene; 2016 Jul; 35(29):3796-806. PubMed ID: 26640152
[TBL] [Abstract][Full Text] [Related]
17. PALB2 analysis in BRCA2-like families.
Adank MA; van Mil SE; Gille JJ; Waisfisz Q; Meijers-Heijboer H
Breast Cancer Res Treat; 2011 Jun; 127(2):357-62. PubMed ID: 20582465
[TBL] [Abstract][Full Text] [Related]
18. Molecular analysis of PALB2-associated breast cancers.
Lee JEA; Li N; Rowley SM; Cheasley D; Zethoven M; McInerny S; Gorringe KL; James PA; Campbell IG
J Pathol; 2018 May; 245(1):53-60. PubMed ID: 29431189
[TBL] [Abstract][Full Text] [Related]
19. Identification of germline genetic mutations in patients with pancreatic cancer.
Salo-Mullen EE; O'Reilly EM; Kelsen DP; Ashraf AM; Lowery MA; Yu KH; Reidy DL; Epstein AS; Lincoln A; Saldia A; Jacobs LM; Rau-Murthy R; Zhang L; Kurtz RC; Saltz L; Offit K; Robson ME; Stadler ZK
Cancer; 2015 Dec; 121(24):4382-8. PubMed ID: 26440929
[TBL] [Abstract][Full Text] [Related]
20. The evolving (epi)genetic landscape of pancreatic neuroendocrine tumours.
Pipinikas CP; Berner AM; Sposito T; Thirlwell C
Endocr Relat Cancer; 2019 Aug; 26(9):R519-R544. PubMed ID: 31252410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
